Citi Starts Esperion Therapeutics (ESPR) at Buy

July 22, 2013 6:57 AM EDT Send to a Friend
Get Alerts ESPR Hot Sheet
Price: $90.65 +2.43%

Rating Summary:
    5 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 10 | Down: 19 | New: 37
Trade ESPR Now!
Join SI Premium – FREE
Citi initiated coverage on Esperion Therapeutics (NASDAQ: ESPR) with a Buy rating and a price target of $30.00.

For an analyst ratings summary and ratings history on Esperion Therapeutics click here. For more ratings news on Esperion Therapeutics click here.

Shares of Esperion Therapeutics closed at $17.28 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Hot New Coverage, New Coverage

Related Entities


Add Your Comment